Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Design
|
August 31, 2016
New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical Practice
Marta Tejera-Alhambra, Oscar Palomares, Rebeca Perez de Diego, et al.
Frontiers in Immunology
|
March 11, 2017
Activation of Blood CD3<sup>+</sup>CD56<sup>+</sup>CD8<sup>+</sup> T Cells during Pregnancy and Multiple Sclerosis
Clara de Andrés, Lidia Fernández-Paredes, Marta Tejera-Alhambra, et al.
International Journal of Molecular Sciences
|
July 28, 2012
Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences
Marta Tejera-Alhambra, Bárbara Alonso, Roseta Teijeiro, et al.
Clinical Immunology (Orlando, Fla.)
|
January 14, 2014
Low DPP4 expression and activity in multiple sclerosis
Marta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Journal of Neuroimmunology
|
March 26, 2014
New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids
Clara de Andrés, Marta Tejera-Alhambra, Bárbara Alonso, et al.
Clinical and Experimental Medicine
|
January 10, 2012
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis
Carol Aristimuño, Roseta Teijeiro, Lara Valor, et al.
Plos One
|
June 4, 2015
Plasma biomarkers discriminate clinical forms of multiple sclerosis
Marta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
March 14, 2013
New decision-tree model for defining the risk of reproductive failure
Rocío Ramos-Medina, Áurea García-Segovia, Juan A León, et al.
Clinical Immunology (Orlando, Fla.)
|
June 5, 2017
Multimarker risk stratification approach at multiple sclerosis onset
Lidia Fernández-Paredes, Armanda Casrouge, Jérémie Decalf, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Design
|
August 31, 2016
New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical Practice
Marta Tejera-Alhambra, Oscar Palomares, Rebeca Perez de Diego, et al.
Frontiers in Immunology
|
March 11, 2017
Activation of Blood CD3<sup>+</sup>CD56<sup>+</sup>CD8<sup>+</sup> T Cells during Pregnancy and Multiple Sclerosis
Clara de Andrés, Lidia Fernández-Paredes, Marta Tejera-Alhambra, et al.
International Journal of Molecular Sciences
|
July 28, 2012
Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences
Marta Tejera-Alhambra, Bárbara Alonso, Roseta Teijeiro, et al.
Clinical Immunology (Orlando, Fla.)
|
January 14, 2014
Low DPP4 expression and activity in multiple sclerosis
Marta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
Journal of Neuroimmunology
|
March 26, 2014
New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids
Clara de Andrés, Marta Tejera-Alhambra, Bárbara Alonso, et al.
Clinical and Experimental Medicine
|
January 10, 2012
Sex-hormone receptors pattern on regulatory T-cells: clinical implications for multiple sclerosis
Carol Aristimuño, Roseta Teijeiro, Lara Valor, et al.
Plos One
|
June 4, 2015
Plasma biomarkers discriminate clinical forms of multiple sclerosis
Marta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|
March 14, 2013
New decision-tree model for defining the risk of reproductive failure
Rocío Ramos-Medina, Áurea García-Segovia, Juan A León, et al.
Clinical Immunology (Orlando, Fla.)
|
June 5, 2017
Multimarker risk stratification approach at multiple sclerosis onset
Lidia Fernández-Paredes, Armanda Casrouge, Jérémie Decalf, et al.
Page
of 1